An integrative review: Application of self-efficacy instruments for walking in populations with peripheral arterial disease

被引:6
作者
Caldieraro-Bentley, Angela J. [1 ]
Andrews, Jeannette O. [1 ]
机构
[1] Med Univ South Carolina, Coll Nursing, 99 Jonathan Lucas St, Charleston, SC 29425 USA
关键词
D O I
10.1016/j.jvn.2013.01.002
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: The study objective was to identify which self-efficacy measurement instruments are being used for walking in patients with peripheral arterial disease (PAD), the psychometrics of these instruments, and recommendations for use in research on patients with PAD. Background: PAD is a common problem for individuals with similar risk factors as cardiovascular disease (CVD). Experts recommend a supervised walking program with incremental increases in speed and distance as an initial treatment for patients with intermittent claudication. Because patients may experience pain while walking, there is a tendency to be nonadherent with exercise therapy, and many limit or avoid walking all together, resulting in a sedentary lifestyle. Self-efficacy plays a role in determining a person's confidence in his or her ability to participate in an exercise program. Data sources for this study were PubMed, Cumulative Index of Nursing and Allied Health Literature, PsycINFO, and the Cochrane database. Methods: The integrative review method described by Wittemore and Knafl was used for this review (Wittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs 2005;52:546-53.). Publications were retrieved electronically and reviewed for inclusion on the basis of studies that measured self-efficacy for walking in populations with PAD, peripheral vascular disease, and CVD. The analysis consisted of 9 publications. Results: Only 2 studies were specific to the population with PAD. The remaining studies addressed self-efficacy issues in CVD or congestive heart failure. The analysis identified 4 instruments based on Bandura's Social Cognitive Theory that were used to assess self-efficacy: (1) the Self-Efficacy Expectation Scale, (2) the Self-Efficacy for Managing Chronic Disease Scale, (3) the Performance-Based Efficacy Scale, and (4) the Barriers Self-Efficacy Scale. The Self-Efficacy Expectation Scale was most frequently used in these studies. Conclusions: The use of the Self-Efficacy Expectation Scale instruments for walking in patients with PAD is limited because reliability and validity have been demonstrated in an older, mostly white population with CVD and congestive heart failure. Instruments that encompass the key constructs of self-efficacy, including physical, personal, and environmental aspects, would allow full evaluation with identification of potential explanations for success or failure for the chosen outcome. This should be taken into consideration in future studies when using instruments of self-efficacy.
引用
收藏
页码:118 / 130
页数:13
相关论文
共 36 条
[1]  
Roger V.L., Go A.S., Lloyd-Jones D.M., Et al., Heart disease and stroke statistics 2011 update: a report from the American Heart Association, Circulation, 123, (2011)
[2]  
Allison M.A., Ho E., Denenberg J.O., Et al., Ethnic-specific prevalence of peripheral arterial disease in the United States, Am J Prev Med, 32, pp. 328-333, (2007)
[3]  
Alzamora M.T., Fores R., Baena-Diez J.M., Et al., The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population, BMC Public Health, 10, (2010)
[4]  
Kannel W.B., Skinner J.J., Schwartz M.J., Et al., Intermittent claudication: incidence in the Framingham Study, Circulation, 41, pp. 875-883, (1970)
[5]  
Criqui M.H., Fronek A., Barrett-Connor E., Et al., The prevalence of peripheral arterial disease in a defined population, Circulation, 71, pp. 510-515, (1985)
[6]  
Hirsch A.T., Halverson S.L., Treat-Jacobson D., Et al., The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care, Vasc Med, 6, pp. 87-96, (2001)
[7]  
Hirsch A.T., Criqui M.H., Treat-Jacobson D., Et al., Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, pp. 1317-1324, (2001)
[8]  
Narins C., Wojciech Z., Moss A., Et al., Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction, Arch Intern Med, 164, pp. 440-446, (2004)
[9]  
Novo S., Classification, epidemiology, risk factors, and natural history of peripheral arterial disease, Diabetes Obes Metab, 4, SUPPL 2, (2002)
[10]  
Hirsch A.T., Haskal Z.J., Hertzer N.R., Et al., Peripheral arterial disease: ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interve, J Am Coll Cardiol, 47, pp. 1239-1312, (2006)